Cerity Partners LLC Puma Biotechnology, Inc. Transaction History
Cerity Partners LLC
- $60.5 Billion
- Q3 2025
A detailed history of Cerity Partners LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 10,210 shares of PBYI stock, worth $50,539. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,210
Previous 10,528
3.02%
Holding current value
$50,539
Previous $36,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PBYI
# of Institutions
135Shares Held
35.1MCall Options Held
264KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.4 Million11.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$10.6 Million0.02% of portfolio
-
Acadian Asset Management LLC Boston, MA2.05MShares$10.2 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $226M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...